LexDanaLexDanabeta
Inventor

MATTHEW J. LOMBARDO

Inventor
US

Overview

3→
Patents
2025–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry11%
PatentTitleYear
12,528,786Plasma kallikrein inhibitors202612,492,187Factor XI activation inhibitors202512,459,927Plasma kallikrein inhibitors2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025–2026Patents assigned to MERCK SHARP & DOHME LLC (3)· patent assignee history
2025–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME LLC32025–2026
Locations
LocationPatentsSpan
US32025–2026